Sfoglia per AUTORE
NERO C
Collezione ASL Città di Torino

  

Items : 2

MITO 25.1: A RANDOMIZED, MOLECULAR DRIVEN PHASE II TRIAL OF CARBOPLATIN-PACLITAXELBEVACIZUMAB VS CARBOPLATIN-PACLITAXELBEVACIZUMAB- RUCAPARIB VS CARBOPLATINPACLITAXEL- RUCAPARIB, SELECTED ACCORDING TO HRD STATUS, IN PATIENTS WITH ADVANCED OVARIAN CANCER in International Journal of Gynecological Cancer

2022
ASL Città di Torino
ASL Biella

Musacchio L; Salutari V; Pignata S; Valabrega G; Zavallone L; Cormio G; Mosconi AM; Giolitto S; Camarda F; Ricci C; Zamagni C; Nero C; Carbone MV; Ghizzoni V; Sorio R; Salvatore S; Tronconi F; Savarese A; Scambia G; Lorusso D;

MITO 25.1: A RANDOMIZED, MOLECULAR DRIVEN PHASE II TRIAL OF CARBOPLATINPACLITAXEL- BEVACIZUMAB VS CARBOPLATIN-PACLITAXEL-BEVACIZUMABRUCAPARIB VS CARBOPLATIN-PACLITAXELRUCAPARIB, SELECTED ACCORDING TO HRD STATUS, IN PATIENTS WITH ADVANCED (STAGE III B-C-IV) OVARIAN, PRIMARY PERITONEAL AND FALLOPIAN TUBE CANCER in International Journal of Gynecological Cancer

2022
ASL Città di Torino
ASL Biella

Musacchio L; Salutari V; Pignata S; Valabrega G; Zavallone L; Cormio G; Mosconi AM; Giolitto S; Giudice E; Ricci C; Zamagni C; Nero C; Carbone MV; Ghizzoni V; Sorio R; Siena S; Tronconi F; Savarese A; Scambia G; Lorusso D;